SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-16-003944
Filing Date
2016-11-14
Accepted
2016-11-14 15:28:25
Documents
50
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q fpmi10q_sep302016.htm 10-Q 709509
2 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARB ex31-1.htm EX-31.1 18044
3 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARB ex31-2.htm EX-31.2 18048
4 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO U.S.C. SECTION 1350 AS ex32-1.htm EX-32.1 7352
5 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO U.S.C. SECTION 1350 AS ex32-2.htm EX-32.2 7486
  Complete submission text file 0001654954-16-003944.txt   2629337

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT fpmi-20160930.xml EX-101.INS 370049
7 XBRL TAXONOMY EXTENSION SCHEMA fpmi-20160930.xsd EX-101.SCH 32588
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fpmi-20160930_cal.xml EX-101.CAL 40681
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fpmi-20160930_def.xml EX-101.DEF 52846
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE fpmi-20160930_lab.xml EX-101.LAB 216552
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fpmi-20160930_pre.xml EX-101.PRE 160898
Mailing Address 8 HILLSIDE AVENUE SUITE 207 MONTCLAIR NJ 07042
Business Address 8 HILLSIDE AVENUE SUITE 207 MONTCLAIR NJ 07042 973-744-1565
FLUOROPHARMA MEDICAL, INC. (Filer) CIK: 0001402785 (see all company filings)

IRS No.: 208325616 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-147193 | Film No.: 161994261
SIC: 2835 In Vitro & In Vivo Diagnostic Substances